Summary We examined protein kinase C (PKC) activity in the cytosolic and particulate fractions of homogenates obtained from 25 colorectal adenomas and adjacent normal mucosa in patients with colorectal carcinoma. The total PKC activity of colorectal adenomas was significantly reduced compared with that of normal mucosa in all cases (122 ± 45.8 vs 174 ± 50.5 pmol min-mg-') (means ± s.d.) (P<0.001). The particulate fraction PKC activity of adenomas was also significantly lower than in normal mucosa (71.4 ± 31.3 vs 115 ± 39.6 pmol min-' mg-') (P<0.O01).
kinase, the activity of which is dependent upon Ca2" and phospholipid (Takai et al., 1979; Nishizuka, 1984) . This enzyme is ubiquitous in eukaryotes (Kuo et al., 1980) and appears to play a key role in transmembrane signaling (Nishizuka, 1986) . PKC is activated by 1,2-diacylglycerol, which is formed in response to extracellular signals by the turnover of phosphoinositides (Berridge & Irvine, 1984) and other membrane phospholipids (Lacal et al., 1987) . This activation process involves translocation of cytosolic PKC to the plasma membrane, which in turn leads to the phosphorylation of target molecules, thereby influencing important cellular processes such as proliferation and/or differentiation (Weinstein, 1987) . It has also been suggested that alterations in PKC activity may play a role in the early stages of malignant transformation (Ashendel, 1985) . Kopp et al. showed that in vitro membrane-bound PKC activity was reduced in colonic adenomas and carcinomas when compared to the adjacent normal colonic mucosa, suggesting that alterations within the PKC pathway occurred as an early event in the adenoma-carcinoma sequence (Kopp et al., 1991) .
The purpose of this study was to investigate the PKC activity of colorectal adenomas in comparison with their clinicopathological findings to determine whether or not activation of PKC was a useful biological marker of colonic tumorigenesis. Materials To ensure that only intact tumour tissue and normal mucosa were used for analysis, all ulcerated and necrotic tissue was removed from the tumour specimens and the submucosa and muscularis were removed from the normal tissue samples. The specimens had a wet weight ranging from 250-800 mg.
All specimens were sufficiently large to allow the histological evaluation of tumour tissue adjacent to the tissue sample subjected to enzyme assay. A histological diagnosis was made according to the criteria of Morson (Morson et al., 1979) . To assess the degree of tissue heterogeneity, the amount of each of the following tissue components present was estimated: stromal elements, nontumorous epithelium, and tumorous epithelium. For this purpose a grid on the microscopic field was used (Hennipman et al., 1989) and the proportion of each tissue element was expressed as a percentage of the total. If stromal tissue exceeded 20%, the tumour was excluded from the study. Tissue samples were frozen in acetone-dry ice within 30 min of resection and then stored at -80'C until analysis. The size of adenomas was determined by measuring the longest diameter.
Preparation of subcellular fractions from tissue specimens All procedures were done at 4'C. The tissues were cut into small pieces and homogenised in 5 ml of Buffer A (25 mM Tris-HCI at pH 7.5, 5 mM EDTA, 5 mM ethyleneglycol bis (B-aminoethylether)-N, N, N', N', -tetra-acetic acid, 0.25 mM phenylmethylsulfonyl fluoride, 10 ml-' leupeptin, 15 mM 2-mercaptoethanol, and 0.25 M sucrose) for 1 min at low speed and then for 5 min at full speed using a Polytron homogeniser. Homogenates were centrifuged at 1,000 g for 10 min to remove the nuclear fraction and any unhomogenised tissue. The resultant supernatant was filtered through glass wool and then centrifuged at 100,000 g for 1 h at 4°C.
The supernatant fraction was then stored at 4°C for use as the 'cytosolic' fraction, while the pellet was solubilised in buffer A containing 1% Triton X-100 (5 ml of Buffer A per gram of tissue) by continuous stirring for 1 h at 4C.
The solubilised pellet was then centrifuged at 100,000 g for 1 h at 4°C, and the resulting supernatant was used as the solubilised 'particulate' fraction (Sakanoue et al., 1991b) . Mini 
DEAE-Sephacel column purification
The cytosolic and particulate fractions were further purified by mini DEAE-Sephacel column chromatography in order to remove inhibitors of PKC or phosphoprotein phosphatase (Sakanoue et al., 199 la). Fractions containing 2 or 5 mg of protein were applied to a 0.5 ml mini DEAE-Sephacel column which was equilibrated in Buffer B (25 mM Tris-HCI at pH 7.5, 0.5 mM EGTA, 0.5 mM EDTA, and 10 mM 2-mercaptoethanol).
The column was then washed with 7.5 ml of Buffer B, and PKC was eluted in 2 ml of Buffer B containing 0.15 M NaCl. The purified fractions thus obtained were used to determine the cytosolic and particulate PKC activity, as described below (Sakanoue et al., 199 la) .
Peptide phosphorylation assay PKC activity was assayed as described previously (Sakanoue et al., 1987 (Bradford, 1976) . All experiments were carried out with at least two tissue preparations and the assays were carried out in duplicate. Specimens were stained with hematoxylin eosine according to standard methods for histological examination. Data are given as the mean ± s.d. and were evaluated by analysis of variance using the Mann-Whitney U-test. The likelihood ratio test (chi-square statistic) was used to provide a statistical assessment of whether adenoma size, histological type, or degree of dysplasia was an independent risk factor for the PKC activity ratio, and P values <0.05 were considered significant.
Results
We examined PKC activity in the cytosolic and particulate fractions extracted from colonic adenomas and the adjacent normal mucosa. The total PKC activity in the adenomas was significantly lower than that in the normal mucosa (122 ± 45.8 vs 174 ± 50.5 pmol min' mg-1) (P<0.001) (Figure 1) . Figure 2 shows that the particulate PKC activity was also significantly lower in adenomas than in the normal mucosa (71.4±31.3 vs 115±39.6pmolmin-' mg-') (P<0.001).
The total and particulate PKC activity of both fractions did not differ with the age and sex of the patients or the location of the adenoma. When the specific activity ratio (adenoma/normal mucosa) was evaluated with respect to adenoma size using linear regression, the particulate fraction PKC activity ratio was found to decrease significantly as the adenoma size increased (Figure 3a ) (test for association: P<0.001, test for linear trend: P<0.001), while the cytosolic fraction ratio was not significantly altered (Figure 3b) .
The relationship of the PKC activity and it's ratio (adenoma/normal mucosa) to the histological appearance of the adenomas is shown in Table I . The particulate specific PKC activity of tubulovillous adenomas was significantly lower than that of tubular adenomas (55.2 ± 28.7 vs 80.4 ± 29.7) (pmol min' mg-') (P<0.05), while there was no significant difference in the cytosolic PKC activity (55.7 ± 25.4 vs 48.0 ± 26.4) (pmol min-' mg-'). The particulate PKC activity ratio (adenoma/normal mucosa) of tubulovillous adenomas was significantly lower than that of tubular adenomas (0.42 ± 0.11 vs 0.77 ± 0.21) (P<0.05), while there was no significant difference in the cytosolic PKC activity ratio (0.78 ± 0.21 vs 0.89 ± 0.34). Table II shows the relationship of the PKC activity and its ratio to the grade of dysplasia. The particulate specific PKC activity with severe dysplasia was lower than that of those with mild dysplasia (55.0 ± 28.1 vs 89.5 ± 33.5) (pmol min-' mg-') (P<0.05), while the cytosolic PKC activity showed no (Jaken et al., 1981; Rodriguez & Rozengurt, 1984) . In addition, down-regulation of PKC has been demonstrated in several cell lines transformed by the ras oncogene (Hsiao et al., 1989 .00 * | | normal mucosa. They suggested that alterations within the 0 | protein kinase C pathway occur as an early event in the adenoma-carcinoma sequence in the intestinal mucosa, and * that PKC had an important role in epithelial differentiation * and growth (Kopp et al., 1991 suggested that the early stages of colonic transformation in humans may involve the translocation of PKC activity, while the later stages might be associated with a reduction in total PKC activity, i.e., down-regulation (Guillem et al., 1987) . However, we did not confirm such a translocation of PKC activity in adenoma tissue and the reason for this is currently unclear. In this content, we showed previously that the cellular distribution (% particulate fraction) of PKC activity in the normal-looking colonic mucosa of patients with colon cancer was significantly higher than in patients without cancer, suggesting that the translocation of PKC activity had already occurred in apparently normal mucosa in the cancer patients (Sakanoue et al., 1991a) . Moreover, Baum et al. have reported that the initial translocation of PKC activity in rat colonic tissue occurred prior to the development of overt tumours (Baum et al., 1990) . Several reports have shown that normal appearing mucosa of carcinoma patients might alternations promoting malignant transformation (Terpstra et al., 1987) . Extensive pathological research has accumulated evidence that small adenomas (1-2 cm in diameter) have a low malignant potential, whereas adenomas over 2 cm in diameter have a much higher rate of malignant transformation, and has shown that the malignant potential of adenomas with severe dysplasia is significantly greater than that of those with mild or moderate dysplasia (Muto et al., 1975; O'Brien et al., 1990 ).
In conclusion, we utilised the specific PKC activity ratio (adenoma/normal mucosa) in the particulate and cytosolic fractions to assess the relationship between PKC activity and malignant potential without bias due to individual variations in activity. Our data showed that a close correlation existed between a decrease in the particulate PKC activity ratio and an increase in the risk of malignant transformation, as predicted by adenoma size, histological type, and degree of dysplasia. In contrast, the cytosolic ratio did not differ significantly with any of these three risk factors. These results suggested a role for down-regulation of particulate PKC in the progression of colonic tumours which appears to be an early event in colonic carcinogenesis. Thus, the PKC activity of colorectal adenomas may potentially be a useful biological indicator of tumour progression.
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